Lawsuit: Mylan Unlawfully Raised Price of EpiPen to Unreasonable Level

A Mylan EpiPen class action lawsuit alleges pharmaceutical company Mylan unlawfully and unfairly raised the price of EpiPens to maximize profits in a market they reportedly already control. Affected parties who purchased an EpiPen or EpiPens manufactured by Mylan after January 1, 2009, may be able to seek compensation with the help of a consumer protection attorney.

If you or a loved one purchased an EpiPen sold by Mylan, contact Attorney Group to learn about your options. We offer free, no obligation consultations. We can help answer your questions, and if you choose to pursue a claim we can connect you with an affiliated attorney who can assist you throughout the legal process.

Important: The time you have to pursue a claim is limited. Contact us for more information.

Claim: High Price of Popular Auto-Injector Could Put Children and Adults at Risk

In November 2016, a Mylan EpiPen class action lawsuit was filed in the state of California claiming that the company committed unconscionable price gouging. According to the lawsuit, Mylan’s unfair increase in the price of EpiPens potentially leaves thousands of California children and adults at risk of death because they are not able to afford the cost of the auto-injectors. Before Mylan acquired the EpiPen in 2007, the auto-injector was priced at $57 per injector. Mylan now charges over $600 per two-pack after having raised the price 15 times in just seven years. The plaintiff in the lawsuit is representing other individuals who purchased EpiPens manufactured and sold by Mylan.

Epinephrine is a medication and hormone used for the emergency treatment of severe allergic reactions caused by foods, insect bites or stings, medicines, or other substances. Approved by the U.S. Food and Drug Administration (FDA) in 1987, the EpiPen is the most popular epinephrine auto-injector on the market, and patients are often advised to keep the medication on hand if they are at risk for a severe allergic reaction.

Mylan’s CEO testified that the price increase was justified because the company needed to recoup over $1 billion it invested “to enhance the product and make it more available.” According to the lawsuit, however, not much has changed with regards to the product’s formula and most of the money spent on the product has been put toward marketing and lobbying costs.

Affected Parties May be Eligible for a Mylan EpiPen Class Action Lawsuit

When pharmaceutical companies gouge the price of their drugs, or otherwise commit unlawful or unfair trade practices, they could be liable for any damages that result. If the allegations of violations of the California Unfair Competition Law and other state consumer statutes regulating unethical acts are proven, individuals and their loved ones may be able to recover the losses they suffered as a result of the defendants’ actions, along with other damages.

Individuals who have purchased EpiPens from Mylan may be eligible to pursue damages through a Mylan EpiPen class action lawsuit and are encouraged to seek the advice of an experienced attorney to learn more about their rights and remedies.

The Time You Have to Pursue a Claim is Limited. Contact Us Today.

For more information, contact Attorney Group. You can fill out the form on this page or contact us by phone or email.

After you contact us, an attorney will follow up to answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.